BLTE
BELITE BIO, INC · Healthcare · Market cap $7.6B(Price slightly stale)
Insiders sold $3.0M net in the last 90 days ·3 sellers, 0 buyers· 2 of 4 sales under Rule 10b5-1 plans· latest Form 4 filed Aug 14, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8.7M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Aug 14, 2026
Chuang Hao-Yuan
BELITE BIO, INC (BLTE) has 26 SEC Form 4 filings (131 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Aug 14, 2026.
Inside the rolling window, 5 insiders at BELITE BIO, INC reported no open-market purchases and 24 open-market sales totaling $8.7M. The most active filer is Chief Scientific Officer MATA NATHAN L. with 17 filings. Insiders have net sold $8.7M over the trailing 6 months. The most recent open-market filing is a sale of 367 shares by Chief Financial Officer Chuang Hao-Yuan, dated Aug 12, 2026, worth $66K.
- Industry:Biotechnology
- CEO:Yu-Hsin Lin
- Employees:41
- HQ:San Diego, CA, US
- IPO:2022-04-29
| Source | |||||||
|---|---|---|---|---|---|---|---|
Chuang Hao-YuanFirst in 4 months | Chief Financial Officer | Sale | 367 | $66K | Aug 14 | +18.9% | SEC ↗ |
Lin Yu-HsinFirst in 4 months | Chief Executive Officer | Sale | 365 | $66K | Aug 14 | +18.9% | SEC ↗ |
| Chief Medical Officer | Sale | 10,000 | $1.5M | Jun 22 | +31.6% | SEC ↗ | |
Scholl Hendrik PeterFirst filing | Chief Medical Officer | Sale | 10,000 | $1.4M | Jun 17 | +30.5% | SEC ↗ |
| Chief Scientific Officer | Sale | 666 | $102K | May 8 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $154K | May 7 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $156K | May 6 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $156K | May 5 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $156K | May 4 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $157K | May 1 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $156K | Apr 30 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $159K | Apr 29 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $163K | Apr 28 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $160K | Apr 27 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $166K | Apr 24 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $170K | Apr 23 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $166K | Apr 22 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $164K | Apr 21 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $160K | Apr 20 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $162K | Apr 20 | — | SEC ↗ | |
MATA NATHAN L.First filing | Chief Scientific Officer | Sale | 1,000 | $168K | Apr 16 | — | SEC ↗ |
Lin Yu-HsinFirst filing | Chief Executive Officer | Sale | 9,200 | $1.7M | Apr 13 | — | SEC ↗ |
Chuang Hao-YuanFirst filing | Chief Financial Officer | Sale | 6,200 | $1.1M | Apr 13 | — | SEC ↗ |
Chen Wan-ShanFirst filing | Director | Sale | 1,100 | $198K | Apr 13 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does BLTE have?
BELITE BIO, INC (BLTE) has 26 SEC Form 4 filings (131 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Aug 14, 2026.
When was the most recent SEC Form 4 filing for BLTE?
The most recent Form 4 filing for BLTE on Tracefour is dated Aug 14, 2026.
Who is the most active insider at BLTE?
The most active SEC Form 4 filer at BLTE in the rolling window is Chief Scientific Officer MATA NATHAN L., with 17 filings.
What is the net insider flow at BLTE over the last 6 months?
Over the trailing 180 days, insiders at BLTE have net sold $8.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at BLTE in the current window?
Inside the rolling window, insiders at BLTE bought $0 and sold $8.7M based on SEC Form 4 filings.
Can I get alerts for BLTE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at BELITE BIO, INC (BLTE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
BELITE BIO, INC is in the Healthcare sector.